Payment overview · 2025
General Payments
$86.58
1 reported records · 1 companies
Healthcare provider profile · identity verified
Rufus A Reuben, MD
Allopathic & Osteopathic Physicians|Internal Medicine · CUYAHOGA FALLS, OH · NPI 1861484883
Verified facts
What the public records show
CMS Open Payments records show Rufus A Reuben, MD received $86.58 in general payments during 2025 across 1 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $86.58 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $86.58 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $86.58 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 860 | 141 |
| Levothyroxine Sodium | Levothyroxine Sodium | 598 | 81 |
| Metoprolol Tartrate | Metoprolol Tartrate | 494 | 79 |
| Amlodipine Besylate | Amlodipine Besylate | 460 | 80 |
| Sertraline Hcl | Sertraline Hcl | 430 | 81 |
| Eliquis | Apixaban | 406 | 55 |
| Lisinopril | Lisinopril | 382 | 70 |
| Trazodone Hcl | Trazodone Hcl | 362 | 59 |
| Gabapentin | Gabapentin | 353 | 60 |
| Furosemide | Furosemide | 345 | 73 |
| Tamsulosin Hcl | Tamsulosin Hcl | 324 | 53 |
| Quetiapine Fumarate | Quetiapine Fumarate | 316 | 51 |
| Metformin Hcl | Metformin Hcl | 310 | 54 |
| Pantoprazole Sodium | Pantoprazole Sodium | 309 | 60 |
| Mirtazapine | Mirtazapine | 303 | 62 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 301 | 46 |
| Potassium Chloride | Potassium Chloride | 263 | 55 |
| Donepezil Hcl | Donepezil Hcl | 245 | 45 |
| Divalproex Sodium | Divalproex Sodium | 238 | 49 |
| Memantine Hcl | Memantine Hcl | 230 | 40 |
| Clopidogrel | Clopidogrel Bisulfate | 223 | 30 |
| Buspirone Hcl | Buspirone Hcl | 198 | 33 |
| Losartan Potassium | Losartan Potassium | 186 | 34 |
| Escitalopram Oxalate | Escitalopram Oxalate | 169 | 27 |
| Risperidone | Risperidone | 153 | 25 |
| Omeprazole | Omeprazole | 150 | 30 |
| Metoprolol Succinate | Metoprolol Succinate | 142 | 32 |
| Hydrochlorothiazide | Hydrochlorothiazide | 138 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 133 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 128 | 18 |
| Baclofen | Baclofen | 120 | 11 |
| Carvedilol | Carvedilol | 120 | 27 |
| Levetiracetam | Levetiracetam | 116 | 19 |
| Olanzapine | Olanzapine | 116 | 34 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 111 | 45 |
| Humalog Kwikpen U-100 | Insulin Lispro | 110 | 29 |
| Simvastatin | Simvastatin | 108 | 27 |
| Famotidine | Famotidine | 95 | 18 |
| Meloxicam | Meloxicam | 88 | 12 |
| Finasteride | Finasteride | 84 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 83 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 83 | 14 |
| Divalproex Sodium Er | Divalproex Sodium | 75 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 75 | suppressed |
| Gemfibrozil | Gemfibrozil | 73 | 15 |
| Torsemide | Torsemide | 73 | 18 |
| Tramadol Hcl | Tramadol Hcl | 73 | 11 |
| Warfarin Sodium | Warfarin Sodium | 70 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 69 | 14 |
| Montelukast Sodium | Montelukast Sodium | 69 | 16 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 67 | 12 |
| Aripiprazole | Aripiprazole | 66 | 15 |
| Lamotrigine | Lamotrigine | 66 | suppressed |
| Allopurinol | Allopurinol | 65 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 65 | 38 |
| Januvia | Sitagliptin Phosphate | 63 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 62 | 25 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 62 | 19 |
| Prednisone | Prednisone | 60 | 23 |
| Propranolol Hcl | Propranolol Hcl | 60 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 59 | 24 |
| Albuterol Sulfate | Albuterol Sulfate | 58 | 11 |
| Spironolactone | Spironolactone | 56 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 52 | 18 |
| Sucralfate | Sucralfate | 52 | suppressed |
| Haloperidol | Haloperidol | 51 | 11 |
| Invega Sustenna | Paliperidone Palmitate | 51 | 12 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 51 | suppressed |
| Topiramate | Topiramate | 49 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 48 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | 11 |
| Benztropine Mesylate | Benztropine Mesylate | 46 | suppressed |
| Myrbetriq | Mirabegron | 46 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 44 | suppressed |
| Lactated Ringers | Ringer's Solution,lactated | 44 | suppressed |
| Latanoprost | Latanoprost | 44 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 42 | suppressed |
| Entresto | Sacubitril/Valsartan | 42 | suppressed |
| Lorazepam | Lorazepam | 42 | 11 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 41 | suppressed |
| Levofloxacin | Levofloxacin | 41 | 22 |
| Rivastigmine | Rivastigmine Tartrate | 41 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 40 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 40 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 40 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 39 | 14 |
| Glipizide | Glipizide | 39 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 39 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 38 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 38 | suppressed |
| Trulicity | Dulaglutide | 37 | suppressed |
| Clozapine | Clozapine | 35 | suppressed |
| Jardiance | Empagliflozin | 35 | suppressed |
| Lactulose | Lactulose | 35 | suppressed |
| Perphenazine | Perphenazine | 34 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 34 | suppressed |
| Ibuprofen | Ibuprofen | 33 | suppressed |
| Calcitriol | Calcitriol | 32 | suppressed |
| Cephalexin | Cephalexin | 32 | 25 |
| Gemtesa | Vibegron | 32 | suppressed |
| Klayesta | Nystatin | 32 | 18 |
| Ramipril | Ramipril | 32 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 31 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 30 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 30 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 29 | suppressed |
| Dimethyl Fumarate | Dimethyl Fumarate | 29 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 29 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Atenolol | Atenolol | 28 | suppressed |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 19 |
| Fenofibrate | Fenofibrate Nanocrystallized | 28 | suppressed |
| Humalog | Insulin Lispro | 28 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 27 | 22 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 27 | 17 |
| Amoxicillin | Amoxicillin | 26 | 14 |
| Budesonide | Budesonide | 26 | suppressed |
| Cimetidine | Cimetidine | 26 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 26 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 25 | suppressed |
| Novolog Flexpen | Insulin Aspart | 25 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 24 | suppressed |
| Trospium Chloride | Trospium Chloride | 24 | suppressed |
| Captopril | Captopril | 23 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 23 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 23 | suppressed |
| Ketoconazole | Ketoconazole | 23 | suppressed |
| Nystatin | Nystatin | 23 | 18 |
| Vraylar | Cariprazine Hcl | 23 | suppressed |
| Brilinta | Ticagrelor | 22 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 22 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 22 | suppressed |
| Xarelto | Rivaroxaban | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 16 |
| Lidocaine Hcl | Lidocaine Hcl | 21 | 20 |
| Lovastatin | Lovastatin | 21 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 20 | suppressed |
| Carbamazepine | Carbamazepine | 20 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 20 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 20 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 20 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 16 |
| Ziprasidone Hcl | Ziprasidone Hcl | 19 | suppressed |
| Glimepiride | Glimepiride | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 17 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 17 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 17 | suppressed |
| Roflumilast | Roflumilast | 17 | suppressed |
| Carisoprodol | Carisoprodol | 16 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 15 | 15 |
| Primidone | Primidone | 15 | suppressed |
| Tradjenta | Linagliptin | 15 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 14 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 14 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Acetazolamide | Acetazolamide | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Ozempic | Semaglutide | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Temazepam | Temazepam | 12 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 12 | suppressed |
| Ampicillin Trihydrate | Ampicillin Trihydrate | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 11 | suppressed |
| Lacosamide | Lacosamide | 11 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Olanzapine Odt | Olanzapine | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $86.58 · 1 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error